Terms: = Brain cancer AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580
20 results:
1. Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma Transforming into Diffuse Large B-Cell Lymphoma in a Young Adult Patient with Neurofibromatosis Type 1: A Case Report.
Kosako H; Yamashita Y; Tanaka K; Mishima H; Iwamoto R; Kinoshita A; Murata SI; Ohshima K; Yoshiura KI; Sonoki T; Tamura S
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557032
[No Abstract] [Full Text] [Related]
2. Molecular determinants of clinical outcomes for anaplastic lymphoma kinase-positive non-small cell lung cancer in Chinese patients: A retrospective study.
Guan M; Xu J; Shi Q
Cancer Genet; 2023 Jan; 270-271():32-38. PubMed ID: 36502690
[TBL] [Abstract] [Full Text] [Related]
3. Costs and Its Determinants in Pituitary Tumour Surgery.
Dekkers AJ; de Vries F; Najafabadi AHZ; van der Hoeven EM; Verstegen MJT; Pereira AM; van Furth WR; Biermasz NR
Front Endocrinol (Lausanne); 2022; 13():905019. PubMed ID: 35872986
[TBL] [Abstract] [Full Text] [Related]
4. Down-regulation of a20 promotes immune escape of lung adenocarcinomas.
Breitenecker K; Homolya M; Luca AC; Lang V; Trenk C; Petroczi G; Mohrherr J; Horvath J; Moritsch S; Haas L; Kurnaeva M; Eferl R; Stoiber D; Moriggl R; Bilban M; Obenauf AC; Ferran C; Dome B; Laszlo V; Győrffy B; Dezso K; Moldvay J; Casanova E; Moll HP
Sci Transl Med; 2021 Jul; 13(601):. PubMed ID: 34233950
[TBL] [Abstract] [Full Text] [Related]
5. Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer.
El Shafie RA; Seidensaal K; Bozorgmehr F; Kazdal D; Eichkorn T; Elshiaty M; Weber D; Allgäuer M; König L; Lang K; Forster T; Arians N; Rieken S; Heussel CP; Herth FJ; Thomas M; Stenzinger A; Debus J; Christopoulos P
ESMO Open; 2021 Jun; 6(3):100161. PubMed ID: 34090172
[TBL] [Abstract] [Full Text] [Related]
6. AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion.
Schuster A; Klein E; Neirinckx V; Knudsen AM; Fabian C; Hau AC; Dieterle M; Oudin A; Nazarov PV; Golebiewska A; Muller A; Perez-Hernandez D; Rodius S; Dittmar G; Bjerkvig R; Herold-Mende C; Klink B; Kristensen BW; Niclou SP
Nat Commun; 2020 Dec; 11(1):6366. PubMed ID: 33311477
[TBL] [Abstract] [Full Text] [Related]
7. Genes associated with inflammation may serve as biomarkers for the diagnosis of coronary artery disease and ischaemic stroke.
Zheng PF; Liao FJ; Yin RX; Chen LZ; Li H; Nie RJ; Wang Y; Liao PJ
Lipids Health Dis; 2020 Mar; 19(1):37. PubMed ID: 32164735
[TBL] [Abstract] [Full Text] [Related]
8. Identification of anaplastic lymphoma kinase fusions in clear cell renal cell carcinoma.
Chen W; Li W; Bai B; Wei H
Oncol Rep; 2020 Mar; 43(3):817-826. PubMed ID: 32020234
[TBL] [Abstract] [Full Text] [Related]
9. TNIP1-mediated TNF-α/NF-κB signalling cascade sustains glioma cell proliferation.
Lei Q; Gu H; Li L; Wu T; Xie W; Li M; Zhao N
J Cell Mol Med; 2020 Jan; 24(1):530-538. PubMed ID: 31691497
[TBL] [Abstract] [Full Text] [Related]
10. Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities.
Hiemcke-Jiwa LS; Leguit RJ; Snijders TJ; Jiwa NM; Kuiper JJW; de Weger RA; Minnema MC; Huibers MMH
Crit Rev Oncol Hematol; 2018 Jul; 127():56-65. PubMed ID: 29891112
[TBL] [Abstract] [Full Text] [Related]
11. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in tnfaip3 followed by mutations in TBL1XR1 and CREBBP.
Jung H; Yoo HY; Lee SH; Shin S; Kim SC; Lee S; Joung JG; Nam JY; Ryu D; Yun JW; Choi JK; Ghosh A; Kim KK; Kim SJ; Kim WS; Park WY; Ko YH
Oncotarget; 2017 Mar; 8(10):17038-17049. PubMed ID: 28152507
[TBL] [Abstract] [Full Text] [Related]
12. In vivo imaging models of bone and brain metastases and pleural carcinomatosis with a novel human EML4-ALK lung cancer cell line.
Nanjo S; Nakagawa T; Takeuchi S; Kita K; Fukuda K; Nakada M; Uehara H; Nishihara H; Hara E; Uramoto H; Tanaka F; Yano S
Cancer Sci; 2015 Mar; 106(3):244-52. PubMed ID: 25581823
[TBL] [Abstract] [Full Text] [Related]
13. Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients.
Wikman H; Westphal L; Schmid F; Pollari S; Kropidlowski J; Sielaff-Frimpong B; Glatzel M; Matschke J; Westphal M; Iljin K; Huhtala H; Terracciano L; Kallioniemi A; Sauter G; Müller V; Witzel I; Lamszus K; Kemming D; Pantel K
Oncotarget; 2014 May; 5(10):3076-87. PubMed ID: 24833255
[TBL] [Abstract] [Full Text] [Related]
14. Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas.
Ben Abdelwahed R; Donnou S; Ouakrim H; Crozet L; Cosette J; Jacquet A; Tourais I; Fournès B; Gillard Bocquet M; Miloudi A; Touitou V; Daussy C; Naud MC; Fridman WH; Sautès-Fridman C; Urbain R; Fisson S
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3657-65. PubMed ID: 23611989
[TBL] [Abstract] [Full Text] [Related]
15. a20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma.
Bellail AC; Olson JJ; Yang X; Chen ZJ; Hao C
Cancer Discov; 2012 Feb; 2(2):140-55. PubMed ID: 22585859
[TBL] [Abstract] [Full Text] [Related]
16. Regulating the TRAIL of destruction: how a20 protects glioblastomas from TRAIL-mediated death.
Verbrugge I; Johnstone RW
Cancer Discov; 2012 Feb; 2(2):112-4. PubMed ID: 22585854
[TBL] [Abstract] [Full Text] [Related]
17. Immunotherapy targeting glioma stem cells--insights and perspectives.
Li Z; Lee JW; Mukherjee D; Ji J; Jeswani SP; Black KL; Yu JS
Expert Opin Biol Ther; 2012 Feb; 12(2):165-78. PubMed ID: 22200324
[TBL] [Abstract] [Full Text] [Related]
18. Insights into ALK-driven cancers revealed through development of novel ALK tyrosine kinase inhibitors.
Lovly CM; Heuckmann JM; de Stanchina E; Chen H; Thomas RK; Liang C; Pao W
Cancer Res; 2011 Jul; 71(14):4920-31. PubMed ID: 21613408
[TBL] [Abstract] [Full Text] [Related]
19. Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia.
Murat A; Migliavacca E; Hussain SF; Heimberger AB; Desbaillets I; Hamou MF; Rüegg C; Stupp R; Delorenzi M; Hegi ME
PLoS One; 2009 Jun; 4(6):e5947. PubMed ID: 19536297
[TBL] [Abstract] [Full Text] [Related]
20. a20 is overexpressed in glioma cells and may serve as a potential therapeutic target.
Guo Q; Dong H; Liu X; Wang C; Liu N; Zhang J; Li B; Cao W; Ding T; Yang Z; Zhang X
Expert Opin Ther Targets; 2009 Jul; 13(7):733-41. PubMed ID: 19492975
[TBL] [Abstract] [Full Text] [Related]
